| Voltaren (U.S.N.L.M.) | ||
|---|---|---|
| Dosing Cataract Surgery | 1 drop qid beginning 24 hours after surgery continuing for 2 weeks | |
| Dosing Corneal Refrctv Surgery | 1 or 2 drops within the hour prior to corneal refractive surgery. 1 or 2 drops within 15 minutes after surgery, and continued 4 times daily for up to 3 days. |
|
| Chem Specs | diclofenac sodium 0.1% | |
| Quantities | 2.5ml, 5ml | |
| Cost | 64.93/5ml, generic | |
| Class | NSAID (COX inhibitor.) | |
| Action | Inhibits prostaglandin synthesis. | |
| Usage | Indicated for postoperative inflammation in cataract extraction and for the temporary relief of pain and photophobia in corneal refractive surgery. |
|
| Discontinue use on evidence of corneal epithelial breakdown. | ||
| Contraindications | Hypersensitive to any component of the medication. | |
| Pediatric use | Safety and effectiveness in pediatric patients have not been established. | |
| Pregnancy | Category C Prostaglandin biosynthesis inhibitors harm the fetal cardiovascular system. | |
| Pregnancy | Category C Prostaglandin biosynthesis inhibitors harm the fetal cardiovascular system. | |
| All topical NSAIDs may slow or delay healing. See package insert for list of warnings and reported adverse events. |
||
| Brand name Voltaren discontinued by Novartis in 2022. Generics available. | ||